Max Healthcare (MAX) delivered in-line performance for 4QFY24. Thequarterly EBITDA continues to inch up since the listing (Aug’20), reachingINR4.9b for 4QFY24. Max has demonstrated superior execution across itshospitals, Max Lab, and Max@home segments, supported by a growingnumber of patients and improved realizations.